Skip to content
Open access

Ventricular Fibrillation in a Patient with Marfan Syndrome without Severe Valvular Disease or Ventricular Dysfunction.

Sep 2026 · International Heart Journal · Vol 67, pp. 512-515 · 0 citations · 7 references
Medicine

TL;DR

This case underscores the risk of VAs in MFS even in the absence of ventricular dysfunction or severe valvular diseases, and a combination of various factors, such as subtle depolarization abnormalities, moderate valvular abnormalities, and underlying myocardial damage, may contribute to the development of VF.

Abstract

An increased incidence of ventricular fibrillation (VF) has been reported in patients with Marfan syndrome (MFS) compared with the general population. Although reduced left ventricular systolic function and severe valvular disease are recognized as major risk factors for ventricular arrhythmias (VAs) in MFS, we report a case of VF that developed despite the absence of these risk factors.A 22-year-old man with MFS who had previously undergone a valve-sparing aortic root replacement with the David procedure, lost consciousness and was diagnosed with VF. After resuscitation, no new abnormal findings were observed except for mild QT prolongation (QTc 471 msec) and a slightly elevated B-type natriuretic peptide level (89.0 pg/mL). An echocardiogram revealed no significant changes compared with the previous examination. It showed that the ejection fraction was preserved and that there was mild aortic valve regurgitation and mild-to-moderate mitral valve regurgitation. Whole-exome sequencing analysis revealed no pathogenic variants, except for an FBN1 variant that was already known to be present. He was diagnosed with idiopathic VF and was implanted a subcutaneous implantable cardioverter-defibrillator.This case underscores the risk of VAs in MFS even in the absence of ventricular dysfunction or severe valvular diseases. A combination of various factors, such as subtle depolarization abnormalities, moderate valvular abnormalities, and underlying myocardial damage, may contribute to the development of VF. More careful surveillance and precise identification of risk factors for arrhythmias are warranted.

Read PDF

Similar papers

Open access Sep 2026

A Clinical Case of Complex Treatment for Tachycardia-Induced Cardiomyopathy

This clinical case demonstrates successful radiofrequency ablation of cavotricuspid isthmus and GDMT in a patient with TIC and Preservation of sinus rhythm was associated with progressive improvement of left ventricle ejection fraction, and quality of life, as well as resolution of clinical symptoms.

O. Gogayeva, Oleksandr O. Nudchenko, O. Beregovyi · 0 citations
Review Oct 2026

Ventricular Arrhythmias in Marfan Syndrome: Prevalence and Clinical Correlates in a Multicenter Cohort.

BACKGROUND Ventricular arrhythmias are increasingly recognized in Marfan syndrome, but associated clinical and structural features remain incompletely defined. METHODS We performed a retrospective multicenter cohort study of 783 adults with confirmed Marfan syndrome at 3 Mayo Clinic sites. Clinical, arrhythmic, echoc...

L. Dreher, H. Abdul Nabi, C. Kanaan et al. · 0 citations
Review Open access Oct 2026

From Diagnosis to Treatment of Arrhythmic Mitral Valve Prolapse and Mitral Annular Disjunction

Mitral valve prolapse (MVP) and mitral annular disjunction (MAD) are common comorbidities that can lead to serious cardiac arrhythmias and sudden cardiac death (SCD). Arrhythmic MVP is characterized by the presence of MVP with frequent (over 5% ventricular extra beats) and/or complex ventricular arrhythmias, such as ve...

Michał Dworak, K. Jaworski, K. Karaban et al. · 0 citations
Open access Oct 2026

Left ventricular diastolic dysfunction predicts new-onset atrial cardiomyopathy in patients with insertable cardiac monitors

Atrial fibrillation (AF) and sick sinus syndrome (SSS) are increasingly recognized as clinical phenotypes of atrial cardiomyopathy (AtCM). Although left ventricular (LV) diastolic dysfunction frequently coexists with AF, its role in the de novo development of AtCM remains unclear. To investigate whether LV...

H. Sumiyoshi, A. Mizukami, A. Nakashima et al. · 0 citations
Open access Oct 2026

Left atrial remodeling parallels ventricular damage and predicts atrial fibrillation in chagas cardiomyopathy

Atrial cardiomyopathy is a frequent complication of Chagas disease, driven by chronic inflammation and fibrosis. We hypothesized that left atrial (LA) remodeling progresses in parallel with left ventricular (LV) damage and predicts new-onset atrial fibrillation (AF). We studied 50 patients with chronic Cha...

P. R. Benchimol Barbosa, B. Kantharia · 0 citations
Open access Oct 2026

Composite biatrial cardiomyopathy severity score and its clinical associations in patients with left-sided valvular heart disease

Atrial cardiomyopathy (ACM) is increasingly recognized as a structural and functional substrate associated with atrial fibrillation (AF) and increased thromboembolic risk [1]. Echocardiographic volumetric and strain parameters enable detailed characterization of atrial structure and function. However, integrated...

A. Markevičiūtė, G. Barauskienė, M. Milasiute et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.